Exjade Approval news, the price tab is approx $80/Gram, it is approved for adults and children above 6 years old, but, children from two to five are indicated if they cannot be adequately treated with desferal. There are certain warnings and conditions of further trials associated with the approval. Novartis has applied for public and private insurance of Exjade. For detalis please read the link below:
http://www.newswire.ca/en/releases/archive/October2006/31/c6142.html>Thanks